Charles Kummeth
2020
In 2020, Charles Kummeth earned a total compensation of $11.5M as President and CEO at Bio-Techne, a 4% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $1,767,957 |
|---|---|
| Option Awards | $4,310,748 |
| Salary | $1,053,000 |
| Stock Awards | $4,310,652 |
| Other | $41,425 |
| Total | $11,483,782 |
Kummeth received $4.3M in option awards, accounting for 38% of the total pay in 2020.
Kummeth also received $1.8M in non-equity incentive plan, $1.1M in salary, $4.3M in stock awards and $41.4K in other compensation.
Rankings
In 2020, Charles Kummeth's compensation ranked 670th out of 13,090 executives tracked by ExecPay. In other words, Kummeth earned more than 94.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 670 out of 13,090 | 95th |
Division Manufacturing | 232 out of 5,617 | 96th |
Major group Chemicals And Allied Products | 75 out of 2,248 | 97th |
Industry group Drugs | 64 out of 1,948 | 97th |
Industry Biological Products, Except Diagnostic Substances | 17 out of 411 | 96th |
Source: SEC filing on September 14, 2022.
Kummeth's colleagues
We found four more compensation records of executives who worked with Charles Kummeth at Bio-Techne in 2020.